Updates are available Correction dated 2025-04-02
Click to view Correction: https://doi.org/10.1038/s41388-025-03369-1
-
Authors
Man, Ki-Fong
Darweesh, Omeed https://orcid.org/0000-0002-6369-296X
Hong, Jinghui
Thompson, Alexandra
O’Connor, Charlotte
Bonaldo, Chiara
Melkonyan, Mark N.
Sun, Mo
Patel, Rajnikant
Ellisen, Leif W. https://orcid.org/0000-0003-0444-7910
Robinson, Tim
Song, Dong
Koh, Siang-Boon https://orcid.org/0000-0002-5494-3800
- License Information
-
More Information
Article History
Received: 22 July 2024
Revised: 17 December 2024
Accepted: 22 January 2025
First Online: 31 January 2025
Change Date: 24 March 2025
Change Type: Update
Change Details: The original online version of this article was revised: In the Acknowledgements section of this article the grant number relating to University of Bristol was incorrectly given as (R101922-123) and should have been ([222064/Z/20/Z]).
Change Date: 2 April 2025
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/s41388-025-03369-1
Competing interests
: LWE has received consulting fees from Gilead, Astra-Zeneca, Mersana, Kisoji and Atavistik, as well as research support from Sanofi, none of which are relevant to this work. TR is a Member of the NICE Breast Cancer guidelines committee, and has received travel support from MSD, Daiichi-Sankyo and Amgen, speaker fee from Novartis, trial funding from Debiopharm and Gilead, as well as consulting fees from BioNTech, none of which are relevant to this work. All other authors declare no potential conflicts of interest.
: All procedures involving human samples were performed in accordance with relevant guidelines and regulations. Studies were approved by institutional review boards (Mass General Brigham Human Research Committee 93-085/2008-P-1789, Ethics Committee of the First Hospital of Jilin University 2023-727). Informed consent was obtained from participants.
